Ignite Creation Date:
2024-05-06 @ 8:26 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02731677
Status:
COMPLETED
Last Update Posted:
2016-04-07
First Post:
2016-03-22
Brief Title:
Acupuncture as Adjuvant Therapy for Sleep Disorders in Parkinsons Disease
Sponsor:
Universidade Federal de Pernambuco
Organization:
Universidade Federal de Pernambuco
Study Overview
Official Title:
Acupuncture as Adjuvant Therapy for Sleep Disorders in Parkinsons Disease
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Sleep disorders correspond to a non-motor symptom present in DP being represented by daytime sleepiness and maintenance insomnia This study aims to evaluate the effects of acupuncture on sleep disorders in patients with PD assisted by Pró-Parkinson Program at University Hospital of Pernambuco Brazil Its a randomized clinical trial approved by the Ethics Committee for Research with Human It was included patients with diagnosed with Idiopathic Parkinsons disease Mini Mental State Examination MMEE according to education stages 1 2 and 3 in the Hoehn-Yahr scale It was used the sleep Scale for Parkinsons disease PDSS a self-administered scale designed to assess nighttime sleep problems sleep disorders and excessive daytime sleep Twenty-two subjects were allocated in two groups experimental and control Acupuncture was applied on the acupoints F3 - BP6- VB34- IG4 - TA5 - C7 - PC6 - IG11 - VB20 - XIAOCHANXUE once a week eight sessions in the experimental group The control group no suffered intervention The paired analyzes were performed using the Wilcoxon test and the independent analyzes using the Mann-Whitney test
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None